by Jordana Choucair | Apr 25, 2022 | Public Health/Prevention
The Centers for Disease Control and Prevention (CDC) released data on Friday showing that COVID-19 was the third leading cause of death in the United States in 2021. According to the data there were 415,000 COVID-19 deaths last year. COVID-19 was also the...
by Jordana Choucair | Apr 22, 2022 | Inequities and SDOH
The Health Equity Project, in conjunction with Third Horizon Strategies (THS), Pareto Intelligence, and Algorex Health, released a new issue brief exploring the impacts of social isolation and loneliness on health outcomes. Based on a literature review of 24 studies,...
by Jordana Choucair | Apr 22, 2022 | Inequities and SDOH
The U.S. Department of Health and Human Services (HHS) announced the availability of nearly $90 million in American Rescue Plan funding to help health centers identify and reduce health disparities. The funding, which will be allocated through the Health Resources and...
by Jordana Choucair | Apr 22, 2022 | Life Sciences
The federal government has engaged in preliminary talks to buy Japanese drugmaker Shionogi & Co.’s experimental COVID-19 antiviral pill. Shionogi’s treatment is in late-stage clinical trials and hasn’t yet been authorized, but previous studies...
by Jordana Choucair | Apr 22, 2022 | M&A
Massachusetts Attorney General Maura Healey approved UnitedHealth Group Inc.’s plan to buy Atrius Health. The decision puts UnitedHealth’s bid to expand its Optum Health provider business by taking over one of the biggest independent physician groups in the...
by Jordana Choucair | Apr 22, 2022 | Payers
Humana announced it will divest 60 percent of its stake in Kindred at Home’s hospice business to an investment firm. The $2.8 billion cash deal is expected to close in the third quarter of this year. Once it closes, Kindred at Home Hospice will be reconfigured...
Recent Comments